REPRESENTACIONES E INVESTIGACIONES MEDICAS; S.A. DE C.V.
发明人:
GARCÍA ARMENTA, MARÍA ELENA,SANTOS MURILLO, JOSEFINA,ÁLVAREZ OCHOA, VÍCTOR GUILLERMO,ESPINOZA ABDALA, LEOPOLDO DE JESUS
申请号：
PL08778975
公开号：
PL2168584T3
申请日:
2008.07.04
申请国别(地区):
PL
年份:
2015
代理人:
摘要：
The present invention concerns a pharmaceutical composition formed by the synergistic combination of a selective serotonin reuptake inhibitor, such as the active principle: Paroxetine hydrochloride hemihydrate and an agent belonging to the triazolobenzodiazepine group, such as the active principle: Alprazolam, as well as pharmaceutically acceptable excipients； which are formulated in a single dosing unit to be administered by oral means, said unit being prescribed for the treatment and control of major depressive episodes, symptoms of Obsessive-Compulsive disorder (OCD), panic attacks with or without agoraphobia, generalized anxiety disorders, social phobia and post-traumatic stress disorder.
